Targeted therapy
December 15, 2021
Dr. Michael Atkins, a medical oncologist who specializes in melanoma, talks about the results of the DREAMseq trial and how the information will hopefully extend life for more patients with advanced melanoma
June 24, 2021
Each arm of NCI-MATCH—and every patient who participates—provide valuable information on potential cancer treatments.
February 12, 2020
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.
February 9, 2020
Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.